UPLC-MS for metabolomics: a giant step forward in support of pharmaceutical research

被引:60
作者
Nassar, Ala F. [1 ,2 ]
Wu, Terence [3 ]
Nassar, Samuel F. [4 ,5 ]
Wisnewski, Adam V. [1 ]
机构
[1] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA
[2] Univ Connecticut, Dept Chem, 55 North Eagleville Rd, Storrs, CT USA
[3] Yale Univ, West Campus Analyt Core, West Haven, CT USA
[4] Yale Sch Med, Dept Neurol, New Haven, CT 06511 USA
[5] Yale Sch Med, Dept Immunobiol, New Haven, CT 06511 USA
关键词
MASS-SPECTROMETRY; DRUG DISCOVERY; CRITICAL PATH; METABOLISM; STRATEGIES; BIOMARKERS; ACID; METABONOMICS; CONSORTIUM; SARCOSINE;
D O I
10.1016/j.drudis.2016.11.020
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Metabolomics is a relatively new and rapidly growing area of post-genomic biological research. As use of metabolomics technology grows throughout the spectrum of drug discovery and development, and its applications broaden, its impact is expanding dramatically. This review seeks to provide the reader with a brief history of the development of metabolomics, its significance and strategies for conducting metabolomics studies. The most widely used analytical tools for metabolomics: NMR, LC-MS and GC-MS, are discussed along with considerations for their use. Herein, we will show how metabolomics can assist in pharmaceutical research studies, such as pharmacology and toxicology, and discuss some examples of the importance of metabolomics analysis in research and development.
引用
收藏
页码:463 / 470
页数:8
相关论文
共 56 条
  • [1] Metabolomic profiling of asthma and chronic obstructive pulmonary disease: A pilot study differentiating diseases
    Adamko, Darryl J.
    Nair, Parameswaran
    Mayers, Irvin
    Tsuyuki, Ross T.
    Regush, Shana
    Rowe, Brian H.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 136 (03) : 571 - +
  • [2] The biomarkers consortium: On the critical path of drug discovery
    Altar, C. A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (02) : 361 - 364
  • [3] [Anonymous], SURV EP END RES SEER
  • [4] The role of choline in prostate cancer
    Awwad, Hussain Mohamad
    Geisel, Juergen
    Obeid, Rima
    [J]. CLINICAL BIOCHEMISTRY, 2012, 45 (18) : 1548 - 1553
  • [5] AMPA receptor-mTOR activation is required for the antidepressant-like effects of sarcosine during the forced swim test in rats: insertion of AMPA receptor may play a role
    Chen, Kuang-Ti
    Tsai, Mang-Hung
    Wu, Ching-Hsiang
    Jou, Ming-Jia
    Wei, I-Hua
    Huang, Chih-Chia
    [J]. FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2015, 9
  • [6] Urinary metabolomics in Fxr-null mice reveals activated adaptive metabolic pathways upon bile acid challenge
    Cho, Joo-Youn
    Matsubara, Tsutomu
    Kang, Dong Wook
    Ahn, Sung-Hoon
    Krausz, Kristopher W.
    Idle, Jeffrey R.
    Luecke, Hans
    Gonzalez, Frank J.
    [J]. JOURNAL OF LIPID RESEARCH, 2010, 51 (05) : 1063 - 1074
  • [7] Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite?
    Choi, Stephen Yiu Chuen
    Collins, Colin C.
    Gout, Peter W.
    Wang, Yuzhuo
    [J]. JOURNAL OF PATHOLOGY, 2013, 230 (04) : 350 - 355
  • [8] Characterization of Hepatocellular Carcinoma Related Genes and Metabolites in Human Nonalcoholic Fatty Liver Disease
    Clarke, John D.
    Novak, Petr
    Lake, April D.
    Shipkova, Petia
    Aranibar, Nelly
    Robertson, Donald
    Severson, Paul L.
    Reily, Michael D.
    Futscher, Bernard W.
    Lehman-McKeeman, Lois D.
    Cherrington, Nathan J.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (02) : 365 - 374
  • [9] Clinical metabolomics paves the way towards future healthcare strategies
    Collino, Sebastiano
    Martin, Francois-Pierre J.
    Rezzi, Serge
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 75 (03) : 619 - 629
  • [10] BENZYLOXIME DERIVATIVES OF STEROIDS - NEW METABOLIC PROFILE PROCEDURE FOR HUMAN URINARY STEROIDS
    DEVAUX, PG
    HORNING, MG
    HORNING, EC
    [J]. ANALYTICAL LETTERS, 1971, 4 (03) : 151 - &